Protease Inhibitor Cocktail (EDTA-Free,100× in DMSO) |
| Catalog No.GK10014 |
El cóctel de inhibidores de proteasas se utiliza en lisados celulares o extractos de tejidos para aumentar la estabilidad de las proteínas.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Environ Pollut (2025)：126520.PMID:40414412
- Cell Death Dis 12.12 (2021)：1126.PMID:34862372
- Cell Death Dis 16.1 (2025)：278.PMID:40216763
- Sci China Life Sci (2025)：1-17.PMID:39821828
- Cell Commun Signal 22.1 (2024)：1-24.PMID:38610001
- Inflamm Res 72.9 (2023)：1773-1787.PMID:37659014
- Cell Rep 44.7 (2025).PMID:40638388
- Cell Rep 43.8 (2024).PMID:39106181
- Biochem Pharmacol (2024)：116230.PMID:38643905
- Mol Med 30.1 (2024)：1-14.PMID:38760717
- Cell Death Discov 11.1 (2025)：46.PMID:39905004
- Mol Med 30.1 (2024)1-18.PMID:39138413
- Cell Mol Life Sci 81.1 (2024)：459.PMID:39562370
- Ecotox Environ Safe 303 (2025)：118985.PMID:40897055
- Food Funct (2024).PMID:38602356
- Ecotox Environ Safe 305 (2025)：119284.PMID:41138456
- Int Immunopharmacol 130 (2024)：111750.PMID:38442577
- Neural Regen Res 18.12 (2023)：2711-2719.PMID:37449635
- Front Pharmacol 12 (2021)：735194.PMID:34880751
- Front Cell Infect Mi 12 (2022)：877265.PMID:35444960
- Int Immunopharmacol 130 (2024)：111811.PMID:38457929
- Front Pharmacol 13 (2022)：938134.PMID:36210836
- Available at SSRN 5208170.PMID:40908478
- Acs Infect Dis 10.3 (2024)：988-999.PMID:38317607
- Biomacromolecules (2025).PMID:40908478
- Geroscience (2024)：1-18.PMID:38922380
- Skeletal Muscle 14 (2024).PMID:39026344
- ACS Infect Dis 7.4 (2021)：777-789.PMID:33723986
- Drug Des Dev Ther (2025)：1681-1701.
- Acs Infect Dis (2024).PMID:38317607
- J Ethnopharmacol (2023)：117537.PMID:38043756
- J Cell Mol Med 29.12 (2025)：e70650.PMID:40551312
- Front Pharmacol 15 (2024)：1477122.PMID:39697555
- Acta Bioch Bioph Sin 55.10 (2023)：1561.PMID:37635409
- Faseb J 39.14 (2025)：e70765.PMID:40641280
- Faseb J 39.14 (2025)：e70765.PMID:40641280
- Funct Integr Genomic 25.1 (2025)：209.PMID:41081959
- Bioengineered 13.4 (2022)：9197-9210.PMID:35383533
- Behav Brain Res 433 (2022)：114002.PMID:35810999
- Mol Med Rep 30.1 (2024)：1-11.PMID:38757346
- Acta Bioch Bioph Sin 56.7 (2024)：1022.PMID:38818581
- J Pharm Pharmacol (2024)：rgae060.PMID:38767973
- Biomol Biomed (2024).PMID:38958450
- Biomolecules and Biomedicine (2024).PMID:38958450
- J Gastrointest Canc 56.1 (2025)：1-21.PMID:40208395
- Acta Crystallogr F (2024).PMID:38818823
- Int Immunopharmacol 116 (2023)：109637.PMID:36764283
- Adv Funct Mater (2024)：2305827.
- Arch Toxicol 96.3 (2022)：767-781.PMID:35088107
- Redox Biol 65 (2023)：102824.PMID:37517320
- J Control Release 372 (2024)：778-794.PMID:38936744
- Iscience 26.4 (2023).PMID:37035004
Protease inhibitor cocktail is used in cell lysates or tissue extracts to increase protein stability.
Endogenous proteins are produced and removed in a balanced state, so their cellular levels are generally stable under stable environmental conditions. However, protein production is greatly halted and degradation is enhanced when cells are studied in vitro. To prevent the degradation of proteins under such conditions, one can utilize a cocktail of inhibitors of those enzymes known to be present.
Protease inhibitor cocktail is used in cell lysates or tissue extracts to increase protein stability. The cocktail functions to inhibit proteases that would degrade either phosphorylated or non-phosphorylated protein substrates.
Protease inhibitor cocktail has been optimized and tested for mammalian cell and tissue extracts. It contains inhibitors with a broad specificity for serine, cysteine, and acid proteases, and aminopeptidases. This cocktail is supplied as a ready-to-use solution in DMSO.
| Ingredient | Summary | CAS Number | Targets |
| AEBSF.HCl | Serine protease inhibitor | 30827-99-7 | Proteases|Serine Protease |
| Aprotinin | Inhibitor of bovine pancreatic trypsin | 9087-70-1 | Proteases|Serine Protease |
| Bestatin | Aminopeptidase inhibitor | 58970-76-6 | Proteases|Aminopeptidase |
| E-64 | Cysteine protease inhibitor,irriversible | 66701-25-5 | Proteases|Cathepsin |
| Leupeptin, Microbial | Inhibitor of serine and cysteine proteases | 103476-89-7 | Proteases|Serine Protease |
| Pepstatin A | Aspartic proteinases inhibitor | 26305-03-3 | Proteases|Other Proteases |
Thaw at room temperature, add at 1:100 (v/v) dilution to solution samples (such as cell lysates or tissue extracts), before assaying.
Application Fields: Western Blot analysis, Co-IP, pull-down, IF, IHC, kinase assay and etc.
- View current batch:
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *